Patrick Legembre
5Patents
0h-index
11Co-inventors
34Inventor score
Filing activity: Sep 24, 2014 → Apr 19, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10189887B2 | Polypeptides and uses thereof for reducing CD95-mediated cell motility | Physics | 0 | Active |
| US11905253B2 | Compounds and pharmaceutical compositions for reducing CD95-mediated cell motility | Chemistry; Metallurgy | 0 | Active |
| US9656984B2 | PI3K/AKT/mTOR inhibitors and pharmaceutical uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10556941B2 | Polypeptides and uses thereof for reducing CD95-mediated cell motility | Physics | 0 | Active |
| US9851358B2 | Methods and pharmaceutical compositions for preventing or reducing metastatic dissemination | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.